Business
People of color shouldn’t be treated equally in COVID-19 vaccine trials, ER doctor says: They should be over-represented – MarketWatch
Ensuring that there’s a diverse group of participants is ‘a bottom line issue’ for investors, the emergency room physician says
This interview is part of a series of conversations MarketWatch is conducting with some of the leading voices in the U.S. on the COVID-19 pandemic.Dr. Esther Choo, an emergency room physician who studies racism and sexism in medicine, says there should be a disproportionate representation of people of color in the COVID-19 vaccine studies. BioNTech SE
BNTX,
+4.10%
,
Moderna Inc.
MRNA,
-2.17%
,
and Pfizer Inc.
PFE,
+3.83%
have publicly said theyre pushing to enroll a more di…
-
Business21 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News20 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General15 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News17 hours agoTips to improve engagement – Proctor